AI CAD System for COVID-19 Lung Severity Assessment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current CAD systems for assessing lung function in COVID-19 patients are limited in their ability to accurately differentiate between severe and mild/moderate cases due to variations in X-ray image quality.

Innovation Solution

A novel CAD system utilizing AI and machine learning techniques that extracts rotation, scaling, and translation invariant X-ray image markers to capture both local and global features of the lung, enabling objective differentiation between severe and non-severe COVID-19 cases.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional CAD systems are used to assess lung function in COVID-19 patients, then the assessment process can be performed, but the accuracy in differentiating between severe and mild/moderate cases is limited due to variations in X-ray image quality

Engineering Contradiction:
Improveaccuracy in differentiating disease severityVSAvoidconsistency across varying X-ray image qualities
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The system transforms X-ray images into a standardized representation space using domain adaptation techniques, changing the parameter space in which disease severity is assessed. This normalization process adjusts for variations in image quality, exposure, and acquisition parameters, enabling consistent and accurate severity differentiation across diverse X-ray datasets.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces an intermediary domain adaptation layer between the X-ray images and the disease severity assessment model. This intermediary component acts as a mediator that harmonizes the input images, removing the influence of acquisition variations and ensuring that the assessment relies on genuine disease severity markers rather than image quality artifacts.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If AI-based methods are applied to detect COVID-19, then detection capability is improved, but the system complexity increases

Engineering Contradiction:
Improvedetection capabilityVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system segments the AI-based assessment into distinct functional modules: image acquisition, domain adaptation, feature extraction, and severity classification. This segmentation allows each component to be optimized independently and facilitates easier implementation and maintenance while maintaining high detection capability through specialized algorithms in each module.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent replaces complex manual radiological assessment with automated AI-based computational methods. The mechanical system of human radiologist interpretation is substituted with digital image processing and machine learning models, reducing subjectivity and increasing consistency while managing complexity through software-based solutions that can be updated and refined.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Loss of information

If chest radiography is used for evaluation, then it provides useful diagnostic information, but it cannot reliably distinguish between severe and mild cases due to image quality variations

Engineering Contradiction:
Improvediagnostic informationVSAvoidseverity differentiation accuracy
Core Design Contradiction:
Loss of informationVSMeasurement precision

Solution Approach 1:

The system adds a new dimension to the analysis by transforming 2D X-ray images into a standardized representation space through domain adaptation. This dimensional transformation creates an additional layer of processing that separates genuine disease severity information from image quality variations, enabling precise severity differentiation while preserving all diagnostic information from the original images.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Data Source

PatentUS12217432B2Assessment of pulmonary function in coronavirus patients
Publication Date: 2025.02.04 UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION INC
  • US12217432B2 patent drawing
  • US12217432B2 patent drawing
  • US12217432B2 patent drawing

AI summary

Assessment of pulmonary function in coronavirus patients includes use of a computer aided diagnostic (CAD) system to assess pulmonary function and risk of mortality in patients with coronavirus disease 2019 (COVID-19). The CAD system processes chest X-ray data from a patient, extracts imaging markers, and grades disease severity based at least in part on the extracted imaging markers, thereby distinguishing between higher risk and lower risk patients.